FDA Research Opportunity - Functional Antibody assays for Klebsiella
About the role
The FDA Office and Location is at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland. CBER focuses on protecting and enhancing public health through the regulation of biological and related products.
Research Project
Multiple groups at CBER are developing vaccines targeting Klebsiella pneumoniae, a significant cause of hospital-acquired infections. Functional antibody assays are needed to evaluate these vaccines against various serotypes. You will learn to develop and implement assays like serum bactericidal antibody assays and opsonophagocytic antibody assays.
Learning Objectives
- Gain experience in bioassay development.
- Learn how to design and implement bioassays and analyze data.
- Learn and become proficient in functional antibody assays.
- Advance professional development in vaccine evaluation.
Mentor
The mentor for this opportunity is Sharon Tennant (Sharon.Tennant@fda.hhs.gov).
Anticipated Appointment Start Date
Summer 2026. Start date is flexible and depends on various factors.
Appointment Length
The appointment will initially be for one year, but may be renewed based on performance and funding availability.
Level of Participation
The appointment is full-time.
Participant Stipend
The participant will receive a monthly stipend commensurate with educational level and experience.
Citizenship Requirements
This opportunity is available to U.S. citizens and Lawful Permanent Residents (LPR) only.
Qualifications
- Citizen or LPR
- Bachelor's, Master's, or Doctoral Degree in Life Health and Medical Sciences
Application Process
To apply, visit the opportunity page and follow the instructions provided. All documents must be in English or accompanied by an official English translation. Questions can be directed to ORISE.FDA.CBER@orau.org with the reference code for this opportunity.